ZA9710989B - Polyprolyl inhibitors of cyclophilin - Google Patents
Polyprolyl inhibitors of cyclophilinInfo
- Publication number
- ZA9710989B ZA9710989B ZA9710989A ZA9710989A ZA9710989B ZA 9710989 B ZA9710989 B ZA 9710989B ZA 9710989 A ZA9710989 A ZA 9710989A ZA 9710989 A ZA9710989 A ZA 9710989A ZA 9710989 B ZA9710989 B ZA 9710989B
- Authority
- ZA
- South Africa
- Prior art keywords
- polyprolyl
- cyclophilin
- inhibitors
- polyprolyl inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76190296A | 1996-12-09 | 1996-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9710989B true ZA9710989B (en) | 1999-05-25 |
Family
ID=25063558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9710989A ZA9710989B (en) | 1996-12-09 | 1997-12-08 | Polyprolyl inhibitors of cyclophilin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0966479A4 (en) |
JP (1) | JP2001505920A (en) |
AR (1) | AR010744A1 (en) |
AU (1) | AU5702698A (en) |
CA (1) | CA2263828A1 (en) |
PA (1) | PA8442401A1 (en) |
WO (1) | WO1998025950A1 (en) |
ZA (1) | ZA9710989B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9912423A (en) | 1998-07-17 | 2001-06-05 | Agouron Pharmaceticals Inc | Pharmaceutically acceptable compounds and / or derivatives, pharmaceutical compositions, methods of treating neurological disorders in patients and processes for preparing pharmaceutically acceptable compounds or derivatives |
WO2001004091A1 (en) | 1999-07-09 | 2001-01-18 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
CA2379149A1 (en) | 1999-07-09 | 2001-01-18 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
WO2001004090A2 (en) | 1999-07-09 | 2001-01-18 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
EE200200442A (en) * | 2000-02-11 | 2003-12-15 | Vertex Pharmaceuticals Incorporated | Piperazine and piperidine derivatives for the treatment of neuronal disorders |
GB0030378D0 (en) | 2000-12-13 | 2001-01-24 | Cyclacel Ltd | Compound |
US6593362B2 (en) | 2001-05-21 | 2003-07-15 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
EP3164148A4 (en) | 2014-06-25 | 2017-12-13 | Cold Spring Harbor Laboratory | Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (emt) in cancer cells |
JP7332620B2 (en) | 2018-04-10 | 2023-08-23 | サノフィ-アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Synthesis of lixisenatide with capping |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
JP2782142B2 (en) * | 1992-07-23 | 1998-07-30 | カルピス株式会社 | Angiotensin converting enzyme inhibitor and method for producing the same |
IL106998A0 (en) * | 1992-09-17 | 1993-12-28 | Univ Florida | Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
JP3089350B2 (en) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | Inhibitors of cyclophilin rotamase activity |
-
1997
- 1997-12-05 PA PA19978442401A patent/PA8442401A1/en unknown
- 1997-12-05 AR ARP970105727A patent/AR010744A1/en unknown
- 1997-12-08 ZA ZA9710989A patent/ZA9710989B/en unknown
- 1997-12-08 JP JP52703798A patent/JP2001505920A/en not_active Withdrawn
- 1997-12-08 CA CA002263828A patent/CA2263828A1/en not_active Abandoned
- 1997-12-08 AU AU57026/98A patent/AU5702698A/en not_active Abandoned
- 1997-12-08 WO PCT/US1997/023102 patent/WO1998025950A1/en not_active Application Discontinuation
- 1997-12-08 EP EP97953231A patent/EP0966479A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2001505920A (en) | 2001-05-08 |
CA2263828A1 (en) | 1998-06-18 |
AR010744A1 (en) | 2000-07-12 |
EP0966479A4 (en) | 2004-12-08 |
EP0966479A1 (en) | 1999-12-29 |
PA8442401A1 (en) | 2000-05-24 |
AU5702698A (en) | 1998-07-03 |
WO1998025950A1 (en) | 1998-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
PL331254A1 (en) | Phosphonianic inhibitors of matrix metaloproteases | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
PL327569A1 (en) | Promedications of thrombosin inhibitors | |
EP0835109A4 (en) | Pyridinone-thrombin inhibitors | |
PL329875A1 (en) | Derivatives of carbolin | |
PL329195A1 (en) | Derivatives of 6-phenylpyridol-2-amine | |
HU9700602D0 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
PL326863A1 (en) | Thrombine inhibitors | |
PL331920A1 (en) | Spirocyclic inhibitors of metaloproteases | |
EP0960191A4 (en) | Compositions and methods for use of defensin | |
PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
GB9425701D0 (en) | Enzyme inhibitors | |
AU2277597A (en) | New inhibitors of sh2-mediated processes | |
ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin | |
HU9702480D0 (en) | New polymorphe modification of doxazosin-mesylate | |
GB9502985D0 (en) | Enzyme inhibitors | |
GB9602704D0 (en) | Structure of perculator | |
HU9702479D0 (en) | New polymorphe modification of doxazosin-mesylate | |
PL328081A1 (en) | Peptidic inhibitors of haematoblast proliferation | |
EP0931091A4 (en) | Inhibitors of pla 2 | |
PL313849A1 (en) | Beta-aminoesters of o-hydrobenzylamides |